Detail
LncRNA Name | NNT-AS1 |
Synonyms | NA |
Region | GRCh38_5:43571594-43603230 Sequence |
Ensembl | ENSG00000248092 |
RefSeq | NR_073113 |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | cervical cancer |
ICD-0-3 | C53 |
Methods | qPCR etc. |
Sample | cervical cancer tissues, cell lines (SiHa, Caski) |
Expression Pattern | up-regulated |
Function Description | NNT-AS1 expression in cervical cancer tissues compared with adjacent non-tumor tissues the overexpression of NNT-AS1 was positively associated with advanced FIGO stage, lymph node metastasis, depth of cervical invasion and poorer overall survival. Function assays showed that NNT-AS1 inhibition could suppress cervical cancer cells proliferation and invasion ability in vitro as well as the activation of Wnt/b-catenin signaling pathway. In vivo mice xenograft model revealed that silencing NNT-AS1 could reduce tumor growth in nude mice. Relative expression levels of NNT-AS1 were upregulated in cervical cancer tissues than in adjacent non-tumor tissues (Fig. 1A; P < 0.05). |
Pubmed ID | 28628975 |
Year | 2017 |
Title | Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/B-catenin signaling pathway in cervical cancer. |
External Links |
Links for NNT-AS1 | GenBank HGNC lncrnadb Noncode |
Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.